# Phase III Trial of Stage I Ovarian Cancer After Surgery

> **NCT04063527** · PHASE3 · RECRUITING · sponsor: **Japanese Gynecologic Oncology Group** · enrollment: 360 (estimated)

## Conditions studied

- Epithelial Ovarian Cancer

## Interventions

- **DRUG:** adjuvant chemotherapy

## Key facts

- **NCT ID:** NCT04063527
- **Lead sponsor:** Japanese Gynecologic Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2012-07-20
- **Primary completion:** 2029-10-01
- **Final completion:** 2030-02-01
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2019-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04063527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04063527, "Phase III Trial of Stage I Ovarian Cancer After Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04063527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*